Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06891482Enrolling by invitation
Home exercise program for dialysis patients
This trial offers a home-based exercise program using technology (like a smartphone app) to help people on dialysis stay active and improve their health. It's designed for Dutch-speaking adults who are stable and willing to try a 6-month program.
Hasselt, HasseltAges Any age - NCT05868876RecruitingPhase 1
Testing AK127 plus AK104 for advanced cancers
This Phase 1 study tests the safety and early anti-cancer activity of AK127 given together with AK104 in people with advanced solid tumors. You may be considered if standard treatments have already been tried or aren’t suitable for you.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06598371RecruitingPhase 1/Phase 2
Study of engineered immune cells for advanced solid tumors
This trial tests a new treatment made from your own immune cells (called tumor-infiltrating lymphocytes) that are genetically modified to fight cancer better. It is for people with certain advanced solid tumors that have not responded well to other treatments.
Houston, TexasAges 18 years+ - NCT07309211Recruiting
Durvalumab as maintenance therapy for limited-stage small cell lung cancer
This trial is for people with limited-stage small cell lung cancer who have already finished chemotherapy and radiation, and then started taking Durvalumab (Imfinzi) as a maintenance therapy. The goal is to see if continuing Durvalumab helps keep the cancer from coming back.
JinanAges 18 years+ - NCT07309276RecruitingPhase 2
Study of JS212 for advanced lung cancer
This trial tests a new drug called JS212 combined with other treatments for people with advanced or spreading lung cancer. It aims to see if the combination can help shrink tumors or slow the disease.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07293533Enrolling by invitation
Heart bypass risk study for planned surgeries
This study looks at patient data from people who had a planned coronary artery bypass graft (heart bypass) to create a better way to predict risks. It may help future patients understand their own surgery risks.
Fortaleza, CearáAges 18 years+ - NCT05717218Recruiting
Testing special breathing monitoring during VV-ECMO in ARDS
This trial checks whether a special “breathing sensor belt” that watches breathing in real time can be used safely in adults with severe lung failure (ARDS) who are on a machine called VV-ECMO. It may help the care team better monitor ventilation while you’re critically ill.
ParisAges 18 years+ - NCT07303530Recruiting
Effect of printing layer thickness on fungus growth in 3D-printed dentures
This trial tests how the thickness of printing layers in 3D-printed dentures affects the growth of Candida albicans, a type of fungus that can cause infections. It aims to find the best design to keep your mouth healthier.
Cairo, Cairo GovernorateAges Any age - NCT07176715Recruiting
Same-day discharge after robotic colon surgery: is it safe?
This study tests whether it is safe for patients to go home the same day after robotic colon surgery. If you are healthy enough and have help at home, you may be able to recover there instead of staying in the hospital overnight.
Phoenix, ArizonaAges 18–70 - NCT07297641Recruiting
Imaging-guided vs X-ray-guided PCI for blocked stents
This trial compares two ways to guide a procedure to reopen a stent that has narrowed again: using a special camera inside the artery (IVUS) versus standard X-ray (angiography). It aims to see which approach works better for people who have a drug-eluting stent that is narrowing for the first time.
Nanjing, JiangsuAges 18–80 - NCT06521255RecruitingPhase 3
New drug combo vs standard for relapsed DLBCL
This trial tests a new combination of drugs (tafasitamab + lenalidomide + gemcitabine + oxaliplatin) against a standard combination (rituximab + gemcitabine + oxaliplatin) for people with DLBCL that has returned or stopped responding to prior therapy. The goal is to see if the new combination works better.
BeijingAges 18 years+ - NCT06498258Recruiting
Wellness support for cancer caregivers in Istanbul
This study tests a psychoeducation program based on positive psychotherapy to help caregivers of cancer patients. It may improve your well-being and caregiving experience.
Kağithane, İ̇stanbulAges 18–65 - NCT05357456Recruiting
Study of brain and memory changes in cortisol-producing adrenal conditions
This study tracks thinking and brain changes over time in people with adrenal findings that produce too much cortisol (a stress hormone) on their own. It may help doctors understand how different treatments or watchful waiting affect the brain and cognition.
Nanjing, JiangsuAges 20–65 - NCT06801470RecruitingPhase 1
Testing the safety of CD-001 in advanced solid tumors
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
TianjinAges 18 years+ - NCT06573411RecruitingPhase 4
Finerenone for primary membranous nephropathy
This trial tests if finerenone, a medicine that may protect the kidneys, can help people with primary membranous nephropathy (a kidney disease that causes protein in urine). It is for adults who are already taking a standard blood pressure medicine but still have protein in their urine.
Guangzhou, GuangdongAges 18 years+ - NCT06971991Recruiting
Measuring liver blood flow during embolization
This study measures blood flow in the liver during a procedure called transarterial embolization, which blocks blood vessels to treat tumors. It may help doctors understand how to better plan treatments for liver conditions.
Madison, WisconsinAges 18 years+ - NCT07161375Recruiting
Using heat camera to predict nerve block success in child hernia surgery
This study tests if a special heat-sensing camera can predict whether a nerve block will work for children having hernia surgery. If successful, this could help doctors know right away if the block is effective.
CairoAges 3 months–6 years - NCT06924944Recruiting
A study of a new lens for people who had laser eye surgery
This study looks at how well a type of artificial lens (Clareon Vivity) works for people who have had laser eye surgery in the past and now need cataract surgery. It aims to see if this lens gives good vision without glasses.
Ogden, UtahAges Any age - NCT07161947Recruiting
Pregnancy diabetes study in Shanghai
This study follows pregnant women with different types of diabetes or at high risk for it. The goal is to understand how blood sugar changes during and after pregnancy and to improve care.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07357207Enrolling by invitation
Video-immunotherapy for advanced breast cancer
This trial tests if a video-based immunotherapy approach can help treat locally advanced breast cancer. It is designed for people who can communicate in Turkish and are comfortable playing video games as part of their treatment.
Izmir, BalcovaAges 18 years+ - NCT07295548Recruiting
Can head and neck flap patients skip the ICU?
This trial compares whether patients recovering from head and neck cancer flap surgery need to stay in the intensive care unit (ICU) or can be safely cared for on a regular surgical ward. The goal is to see if a less intensive recovery is safe and equally effective.
Pavia, LombardyAges Any age - NCT06950086RecruitingPhase 1/Phase 2
TYK-00540 tablets for advanced solid tumors
This trial tests a new tablet, TYK-00540, alone or with another drug, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT04561206RecruitingPhase 2
Brentuximab plus nivolumab for relapsed Hodgkin lymphoma
This Phase 2 trial studies brentuximab vedotin plus nivolumab in people whose classical Hodgkin lymphoma has come back or did not respond to treatment. It aims to shrink tumors and improve control of the disease, especially when standard options like transplant are not possible.
Duarte, CaliforniaAges 18 years+ - NCT06906094Enrolling by invitation
Preventing arthritis after meniscus tear surgery
This trial tests a new approach to prevent arthritis after surgery to remove part of a torn meniscus. It looks at whether a treatment can stop the knee from wearing down after the operation.
Milan, MilanoAges 19 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.